Chemotherapeutic Candidate Inducing Immunological Death of Human Tumor Cell Lines
Authors:
Open Access
- 1 January 2012
- journal article
- Published by The Korean Association of Immunobiologists in Immune Network
- Vol. 12 (2) , 66-9
Abstract
The immunological death induction by EY-6 on the human tumor cell lines was screened. Human colon carcinoma (HCT15, HCT116), gastric carcinoma (MKN74, SNU668), and myeloma (KMS20, KMS26, KMS34) cells were died by EY-6 treatment with dose-dependent manner. CRT expression, a typical marker for the immunological death, was increased on the EY-6-treated colorectal and gastric cancer cells. Interestingly, the effects on the myeloma cell lines were complicated showing cell line dependent differential modulation. Cytokine secretion from the EY-6 treated tumor cells were dose and cell-dependent. IFN-γ and IL-12 secretion was increased in the treated cells (200% to over 1000% of non-treated control), except HCT116, SNU668 and KMS26 cells which their secretion was declined by EY-6. Data suggest the potential of EY-6 as a new type of immuno-chemotherapeutics inducing tumor-specific cell death. Further studies are planned to confirm the efficacy of EY-6 including in vivo study.Keywords
This publication has 9 references indexed in Scilit:
- Cellular Mechanism of Newly Synthesized Indoledione Derivative-induced Immunological Death of Tumor CellImmune Network, 2011
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure PathwayClinical Cancer Research, 2010
- Immunizations With IFNγ Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat GliomasJournal of Immunotherapy, 2009
- Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to ImmunogenicCancer Research, 2007
- Calreticulin exposure dictates the immunogenicity of cancer cell deathNature Medicine, 2006
- Modulation of IFN-γ production by TNF-α in macrophages from the tumor environment: Significance as an angiogenic switchInternational Immunopharmacology, 2006
- Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the PhagocyteCell, 2005
- Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression.1991